These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17380261)

  • 21. Limitations of polyethylene glycol-induced precipitation as predictive tool for protein solubility during formulation development.
    Hofmann M; Winzer M; Weber C; Gieseler H
    J Pharm Pharmacol; 2018 May; 70(5):648-654. PubMed ID: 28106257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.
    Cheng L; Lei L; Guo S
    Int J Pharm; 2010 Mar; 387(1-2):129-38. PubMed ID: 20005928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confocal microscopy for the elucidation of mass transport mechanisms involved in protein release from lipid-based matrices.
    Koennings S; Tessmar J; Blunk T; Göpferich A
    Pharm Res; 2007 Jul; 24(7):1325-35. PubMed ID: 17457662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steady-state tryptophan fluorescence spectroscopy study to probe tertiary structure of proteins in solid powders.
    Sharma VK; Kalonia DS
    J Pharm Sci; 2003 Apr; 92(4):890-9. PubMed ID: 12661074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissolution from solid lipid extrudates containing release modifiers.
    Güres S; Kleinebudde P
    Int J Pharm; 2011 Jun; 412(1-2):77-84. PubMed ID: 21515350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
    Tran PH; Tran HT; Lee BJ
    J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the major positional isomer of pegylated interferon alpha-2b.
    Wang YS; Youngster S; Bausch J; Zhang R; McNemar C; Wyss DF
    Biochemistry; 2000 Sep; 39(35):10634-40. PubMed ID: 10978146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alginate/polyethylene glycol blend fibers and their properties for drug controlled release.
    Wang Q; Zhang N; Hu X; Yang J; Du Y
    J Biomed Mater Res A; 2007 Jul; 82(1):122-8. PubMed ID: 17269140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of poly(ethylene glycol)-metaxalone conjugates and study of its controlled release in vitro.
    Zhang J; Fan X; Liu Y; Bo L; Liu X
    Int J Pharm; 2007 Mar; 332(1-2):125-31. PubMed ID: 17067768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: development of a novel process for obtaining a dry, stable powder.
    Sharma VK; Kalonia DS
    AAPS PharmSci; 2004 Jan; 6(1):E4. PubMed ID: 15198505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temperature/pH Responsive Hydrogels Based on Poly(ethylene glycol) and Functionalized Poly(e-caprolactone) Block Copolymers for Controlled Delivery of Macromolecules.
    Nikouei NS; Ghasemi N; Lavasanifar A
    Pharm Res; 2016 Feb; 33(2):358-66. PubMed ID: 26415645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin in aqueous solutions.
    Taluja A; Bae YH
    Pharm Res; 2007 Aug; 24(8):1517-26. PubMed ID: 17385016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled release implants based on cast lipid blends.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Sci; 2011 May; 43(1-2):78-83. PubMed ID: 21463679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
    Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
    Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling drug release from hot-melt extruded mini-matrices with constant and non-constant diffusivities.
    Verhoeven E; Siepmann F; De Beer TR; Van Loo D; Van den Mooter G; Remon JP; Siepmann J; Vervaet C
    Eur J Pharm Biopharm; 2009 Oct; 73(2):292-301. PubMed ID: 19549569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
    Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
    J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
    Zhang S; Wang J; Pan J
    Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug release mechanisms of compressed lipid implants.
    Kreye F; Siepmann F; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):27-35. PubMed ID: 21055453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.